Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Fulcrum Therapeutics, Inc. (FULC)

Abeona Therapeutics Inc. and Fulcrum Therapeutics, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Fulcrum Therapeutics, Inc. are of similar size ($280.0M and $265.9M). Fulcrum Therapeutics, Inc. grew revenue faster over the last twelve months: 1,939.8% against 427.5%. Fulcrum Therapeutics, Inc. has the higher net margin (0.00% vs −242.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Fulcrum Therapeutics, Inc. leads on 12 and Abeona Therapeutics Inc. on 4.

Valuation

Metric ABEO FULC Biotechnology median
P/E n/m n/m 8.50
P/S 9.68 3.37 9.71
P/B 1.96 0.90 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.43 0.64
EV/Sales 4.60 (0.49) 9.21
Earnings yield (26.59%) (33.15%) (33.15%)
Free cash flow yield (32.48%) (23.60%) (25.50%)

Profitability

Metric ABEO FULC Biotechnology median
Gross margin 66.03% 100.00% 65.16%
Operating margin (322.59%) 0.00% 0.00%
Net margin (242.62%) 0.00% 0.00%
Free cash flow margin (314.53%) 0.00% 0.00%
Return on equity (43.13%) (32.38%) (56.36%)
Return on assets (29.54%) (30.75%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABEO FULC Biotechnology median
Revenue growth (TTM) 427.47% 1,939.80% 6.02%
EPS growth (last fiscal year) 165.16% (637.50%) 30.26%
Revenue growth, 5-year CAGR 14.19% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO FULC Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 31.35 4.72
Net debt to EBITDA 2.00 4.23 0.96

Dividend

Metric ABEO FULC Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABEO FULC Biotechnology median
Market cap 265.90m 280.01m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack